|Bid||0.00 x 1100|
|Ask||0.00 x 1300|
|Day's Range||260.47 - 266.23|
|52 Week Range||155.65 - 280.69|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||9.87|
|Earnings Date||Jul 26, 2021 - Jul 30, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 29, 1994|
|1y Target Est||303.83|
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of March 31st. In this article, we look at what those funds think of Laboratory Corp. of America Holdings (NYSE:LH) based […]
LabCorp (LH) enables evidence-based, personalized treatment suggestions based on the genomic profiling of a patient's solid tumor with the launch of new test.